Article Information
History
- August 31, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Itzel Valencia1,
- Pier Vitale Nuzzo1,
- Edoardo Francini3,
- Francesco Ravera4,
- Giuseppe Nicolò Fanelli1,5,
- Sara Bleve6,
- Cristian Scatena5,
- Luigi Marchionni1 and
- Mohamed Omar1,2,*
- 1Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York 10021 NY, USA
- 2Dana-Farber Cancer Institute, Harvard University, Boston 02215 MA, USA
- 3Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy
- 4Department of Internal Medicine and Medical Specialties, University of Genoa, 16132 Genoa, Italy
- 5Department of Translational Medicine and New Technologies in Medicine and Surgery, University of Pisa, 56125 Pisa, Italy
- 6Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, 47014 Meldola, Italy
- ↵*Correspondence to: Mohamed Omar, MD Department of Pathology and Laboratory Medicine Weill Cornell Medicine 413 E 69th ST, BB-1526 New York, NY 10021, USA Phone: +1 347-277-4017 Email: mao4005{at}med.cornell.edu
Posted August 31, 2024.
Gene Signature for Predicting Metastasis in Prostate Cancer Using Primary Tumor Expression Profiles
